Eli Lilly (LLY) reduced its fourth-quarter sales guidance by 5%, lowering expectations to $13.5 billion. This figure is $400 ...
Investor's Business Daily on MSN30m
Eli Lilly: What's Left To Like? A Lot, Says One Analyst.There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its sales view.
The stock market indexes surged on a tame CPI inflation report, reclaiming key levels. Tesla, Meta led a slew of new buys.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback